Clinical Research Trends

Clinical research trends continue to evolve as new technologies, data sources, regulatory approaches and patient expectations influence how clinical trials are designed and conducted.

Modern clinical research increasingly focuses on improving trial efficiency, data quality, patient participation and evidence generation while maintaining appropriate standards for participant protection and regulatory compliance.

Table of Contents

Decentralized and Hybrid Clinical Trials

Traditional clinical trials generally require participants to attend investigative sites for many study-related activities. Decentralized and hybrid approaches can allow selected activities to take place remotely or closer to participants.

Depending on the study, these approaches may involve:

Telemedicine and virtual visits
Electronic informed consent
Remote patient monitoring
Wearable and connected devices
Electronic patient-reported outcomes
Home health services
Direct-to-patient delivery of appropriate trial supplies

Hybrid trials combine site-based activities with suitable decentralized elements.

These approaches can reduce participant burden and potentially broaden access to clinical research, but they also introduce considerations involving data quality, technology validation, participant privacy, investigator oversight and regulatory compliance.

Artificial Intelligence and Advanced Analytics

Artificial intelligence (AI), machine learning and advanced analytics are increasingly being explored and applied across different areas of clinical research.

Potential applications include:

Identification of suitable study populations
Support for patient recruitment
Analysis of complex datasets
Detection of data-quality issues
Identification of patterns and trends
Support for risk-based monitoring
Automation of selected operational processes
Analysis of medical images or other complex clinical data

The use of AI requires appropriate attention to data quality, validation, transparency, bias, privacy, human oversight and the intended regulatory use of the resulting information.

Real-World Data and Real-World Evidence

Clinical research increasingly makes use of real-world data (RWD) generated during routine healthcare delivery.

Sources may include:

Electronic health records
Disease and product registries
Health insurance claims
Patient-generated data
Digital health technologies
Other healthcare data sources

When appropriately designed and analysed, real-world data may contribute to real-world evidence (RWE) that supports clinical development, safety evaluation and certain regulatory or healthcare decisions.

The reliability and relevance of the underlying data and the appropriateness of the study design remain essential considerations.

Patient-Centric Clinical Research

Patient-centricity involves considering the needs, experiences and perspectives of patients when planning and conducting clinical research.

Patient input may help researchers:

Develop more practical study protocols.
Select meaningful study outcomes.
Reduce unnecessary participant burden.
Improve recruitment and retention strategies.
Develop clearer participant information.
Design more accessible trial procedures.

Engaging patients and patient organisations can help ensure that clinical research addresses outcomes that are meaningful to the populations being studied.

Digital Health Technologies

Digital technologies are expanding the ways in which clinical information can be collected and participants can interact with clinical studies.

Examples include:

Wearable sensors
Mobile applications
Connected medical devices
Electronic diaries
Electronic clinical outcome assessments
Remote monitoring technologies

These tools can enable more frequent or continuous collection of certain types of data outside conventional clinical sites.

Their use requires appropriate consideration of fitness for purpose, validation, data integrity, cybersecurity, privacy and participant usability.

The FDA provides additional recommendations on the use of digital health technologies for remote data acquisition in clinical investigations in its Digital Health Technologies for Remote Data Acquisition in Clinical Investigations guidance.

Risk-Based Quality Management and Monitoring

Clinical-trial quality management is increasingly focused on identifying and managing risks that are important to participant protection and the reliability of trial results.

Risk-based approaches may include:

Identification of critical-to-quality factors
Centralised monitoring
Risk indicators
Targeted site monitoring
Data analytics
Early identification of important quality issues

The objective is not simply to reduce monitoring activities but to focus resources on the areas that are most important to trial quality.

Diversity and Inclusion in Clinical Trials

Improving the representativeness of clinical-trial populations has become an important consideration in clinical development.

Researchers increasingly consider factors such as:

Age
Sex
Race and ethnicity
Geographic location
Socioeconomic circumstances
Disease severity and comorbidities
Barriers to trial participation

More representative trial populations can improve understanding of how medical interventions perform across the populations likely to use them.

Data Integration and Interoperability

Clinical trials increasingly generate information from multiple systems and sources.

These may include electronic data capture systems, electronic health records, laboratory systems, imaging platforms, wearable devices and patient-reported outcome systems.

Greater interoperability and appropriate use of data standards can help improve:

Data exchange
Traceability
Data quality
Operational efficiency
Regulatory submissions
Long-term reuse of research data

Effective data governance remains essential as the volume and complexity of clinical data increase.

Regulatory Trends in Clinical Research

Regulatory authorities continue to develop guidance and requirements addressing innovations in clinical research.

Areas of continuing regulatory development include:

Decentralized trial elements
Digital health technologies
Electronic systems and records
Artificial intelligence
Real-world evidence
Data integrity
Good Clinical Practice
Participant diversity
Risk-based quality management

Sponsors and research organisations should therefore monitor applicable regulatory requirements and current guidance throughout the clinical-development process.

Future Clinical Research Trends

Clinical research trends point toward greater integration of digital technologies, advanced analytics, diverse data sources and patient-centred approaches.

Technology alone, however, does not determine the quality of clinical research. Successful innovation must continue to be supported by sound scientific methodology, reliable data, appropriate regulatory oversight, ethical conduct and protection of clinical-trial participants.

Explore our various programs in clinical research. Explore our Course Catalogue